| # | Drug | Count |
|---|---|---|
| 0 | TREOSULFAN | 27 |
| 1 | ALEMTUZUMAB | 26 |
| 2 | CYCLOPHOSPHAMIDE | 17 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 17 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 17 |
| 5 | METHOTREXATE SODIUM | 10 |
| 6 | CAPECITABINE | 9 |
| 7 | METHYLPREDNISOLONE | 9 |
| 8 | PREDNISONE | 9 |
| 9 | FLUDARABINE PHOSPHATE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TREOSULFAN | 27 | 0.0098 |
| 1 | ACETIC ACID | 1 | 0.0028 |
| 2 | ALEMTUZUMAB | 26 | 0.0013 |
| 3 | CALASPARGASE PEGOL | 1 | 0.0012 |
| 4 | ERTUGLIFLOZIN | 1 | 0.0009 |
| 5 | DECITABINE | 3 | 0.0007 |
| 6 | INSULIN DEGLUDEC AND LIRAGLUTIDE | 1 | 0.0006 |
| 7 | CLOFAZIMINE | 3 | 0.0005 |
| 8 | DACTINOMYCIN | 1 | 0.0005 |
| 9 | METHYLCELLULOSE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 26 | 0.0013 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Actinomycin [EPC] | 1 | 0.0005 |
| 3 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Antimycobacterial [EPC] | 3 | 0.0001 |